PV Panel Test (Jak-2 V617F Reflex To Jak-2 Exon 12 Mutation)-Blood in Powai
50+ booked in last 3 daysOverview
Polycythemia Vera (PV) is a rare blood disorder caused by a genetic mutation in the JAK2 gene. The JAK2 mutation is present in majority of the people with PV. The "PV panel (Jak-2 V617F Reflex to Jak-2 Exon 12 Mutation)-Blood" is designed to diagnose Polycythemia Vera (PV), a myeloproliferative neoplasm characterized by the overproduction of red blood cells. The clinical utility of this test lies in its application for suspected cases of PV. It involves first screening for the Jak-2 V617F mutation, which is commonly associated with PV. If the initial Jak-2 V617F test is negative, a reflex test for Jak-2 Exon 12 Mutation is performed to further investigate the possibility of PV. Detecting these mutations in the blood aids in confirming the diagnosis of PV and allows for timely and appropriate management of the condition.
PV Panel Test (Jak-2 V617F Reflex To Jak-2 Exon 12 Mutation)-Blood Price in Powai
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the PV Panel Test (Jak-2 V617F Reflex To Jak-2 Exon 12 Mutation)-Blood with a clear pricing structure
The price of PV Panel Test (Jak-2 V617F Reflex To Jak-2 Exon 12 Mutation)-Blood in Powai is ₹ 8,480
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.